[PDF][PDF] Summary of product characteristics

I Annex - Committee for Proprietary Medicinal Products. The …, 1999 - farmaceuciszczepia.pl
After dilution, vials of Comirnaty contain 6 doses of 0.3 mL of vaccine. In order to extract 6
doses from a single vial, low dead-volume syringes and/or needles should be used. The low …

[PDF][PDF] Summary of product characteristics

V MR - 2008 - servier.dk
Elderly patients may have increased trimetazidine exposure due to age-related decrease in
renal function (see section 5.2). In patients with moderate renal impairment (creatinine …

The effectiveness of the summary of product characteristics (SmPC) and recommendations for improvement

DK Raynor, P De Veene, D Bryant - Therapeutic Innovation & Regulatory …, 2014 - Springer
… roles of the Summary of Product Characteristics (SmPC) is to … the effectiveness of the
SmPC document in communicating … information in summaries of product characteristics and …

[PDF][PDF] Summary of product characteristics

C Injection - Bexley, Kent, UK: Forest Laboratories UK Ltd, 2004 - hpra.ie
Remifentanil should be co-administered with a hypnotic agent, such as propofol, thiopentone,
or isoflurane, for the induction of anaesthesia. Administering Remifentanil after a hypnotic …

A system for the extraction and representation of summary of product characteristics content

S Rubrichi, S Quaglini, A Spengler, P Russo… - Artificial intelligence in …, 2013 - Elsevier
… of drug information conveyed in the summary of product characteristics (SPC), in the form of
a … We focus on extracting information from two specific sections of SPC concerned with drug-…

[PDF][PDF] Summary of product characteristics

XR Seroquel - … . org. uk/emc/product/6363/smpc (accessed 07 July …, 2003 - hpra.ie
Seroquel XR is indicated for: • treatment of schizophrenia• treatment of bipolar disorder: o For
the treatment of moderate to severe manic episodes in bipolar disorder o For the treatment …

[PDF][PDF] Summary of product characteristics

A Acid, P Properties - Children - hpra.ie
1st Day 23 to 38 mL/kg/d 1.5 to 2.5 g AA/kg/d≥ 2nd Day 38 to 54 mL/kg/d 2.5 to 3.5 g AA/kg/d
Gradual dose increase during the first days of infusion should be used, starting with a dose …

[PDF][PDF] Summary of Product Characteristics

T Patch - 2005 - hpra.ie
Posology Fentadurdoses should be individualised based upon the status of the patient and
should be assessed at regular intervals after application. The lowest effective dose should …

[PDF][PDF] Summary of product characteristics

F Tablet - … at: medicines. org. uk/emc/product/5490/smpc …, 2020 - dra.gov.pk
… Refer to the tenofovir disoproxil fumarate-containing product’s Summary of Product
Characteristics for recommendations on renal monitoring (see section 4.4). Efavirenz/ emtricitabine/ …

[HTML][HTML] The quality and reliability of information in the summaries of product characteristics

E Drelich, U Religioni, K Chung, J Kaźmierczak… - International Journal of …, 2022 - mdpi.com
… The Summary of Product Characteristics (SmPC) is an obligatory document concerning a …
of a medicinal product. The purpose of the SmPC is to provide product information to …